-
Founded in:
2015-09-08 -
Country:
China -
Address:
No. 2, Huanan 4th Road, Economic and Technological Development Zone, Changshou District, Chongqing -
Tax NO.:
915001153556325416 -
Registered Funds:
100 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CARBONNANOPARTICLES |
Extract from the above information
More
Extract from the above information |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CARBONNANOPARTICLES |
No specific pharmacological effects are clearly mentioned from the above information
More
No specific pharmacological effects are clearly mentioned from the above information |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fludarabine phosphate |
This product is a fluorinated nucleoside analog of the antiviral drug Vidarabine. It has an anti-tumor mechanism similar to Ara-C, but is not deaminated and inactivated by adenosine deaminase. After ingestion, it is rapidly dephosphorylated to generate 2-fluoroarabinoadenosine (F-Ara-A), which is phosphorylated in the cell to become F-Ara-ATP with anti-tumor activity. It can inhibit DNA polymerase, DNA primase, DNA helicase and ribonucleotide reductase, and can also be incorporated into tumor cell DNA and RNA chains to stop chain extension and inhibit DNA and RNA synthesis. However, its precise mechanism needs to be further clarified. This product can inhibit the growth of many human tumors, such as non-Hodgkin's lymphoma, leukemia, breast cancer, non-small cell lung cancer and ovarian tumors in tissue culture and tumor animal models, and it also has the effect of enhancing the activity of many anti-tumor drugs in vitro. This product can be used in combination with gallium nitrate, cytarabine, mitoxantrone or Ara-C plus cisplatin to enhance the killing effect on tumor cells.
More
This product is a fluorinated nucleoside analog of the antiviral drug Vidarabine. It has an anti-tumor mechanism similar to Ara-C, but is not deaminated and inactivated by adenosine deaminase. After ingestion, it is rapidly dephosphorylated to generate 2-fluoroarabinoadenosine (F-Ara-A), which is phosphorylated in the cell to become F-Ara-ATP with anti-tumor activity. It can inhibit DNA polymerase, DNA primase, DNA helicase and ribonucleotide reductase, and can also be incorporated into tumor cell DNA and RNA chains to stop chain extension and inhibit DNA and RNA synthesis. However, its precise mechanism needs to be further clarified. This product can inhibit the growth of many human tumors, such as non-Hodgkin's lymphoma, leukemia, breast cancer, non-small cell lung cancer and ovarian tumors in tissue culture and tumor animal models, and it also has the effect of enhancing the activity of many anti-tumor drugs in vitro. This product can be used in combination with gallium nitrate, cytarabine, mitoxantrone or Ara-C plus cisplatin to enhance the killing effect on tumor cells. |
75607-67-9 | 19 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Mycophenolate mofetil |
Extract from the above information
More
Extract from the above information |
115007-34-6 | 54 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Voriconazole |
|
137234-62-9 | 56 |